Pipeline

Roivant Discovery has a differentiated pipeline of targets with high biological and disease validation that have historically been challenging to design therapeutics.

Heterobifunctionals

Target ID
Hit Finding
Hit-to-Lead
Lead Optimization
Preclinical Development

KRAS


ADAR


WRN


Undisclosed


Undisclosed


Undisclosed


Covalency

Target ID
Hit Finding
Hit-to-Lead
Lead Optimization
Preclinical Development

Undisclosed


Undisclosed


Undisclosed


Best-in-Class Small Molecules

Target ID
Hit Finding
Hit-to-Lead
Lead Optimization
Preclinical Development

KRAS


Undisclosed


Undisclosed


Undisclosed